The results of meta-analysis about diabetes remission, HbA1c, FBG, hypoglycemic, antihypertensive, lipid-lowering medications, weight loss, high-density lipoprotein, triglycerides and adverse events 1 Study or Subgroup 1.1.1 Gastric bypass vs MT Geltrude 2012 Philip 2012 Subtotal (95% CI) Heterogeneity: Chi² = 0.01, df = 1 (P = 0.92); I² = 0% Test for overall effect: Z = 5.14 (P < 0.00001)
Total (95% CI)
Heterogeneity: Chi² = 20.70, df = 4 (P = 0.0004); I² = 81% Test for overall effect: Z = 8.93 (P < 0.00001) Test for subgroup differences: Chi² = 20.69, df = 3 (P = 0.0001), I² = 85.5% 
Mean

Total (95% CI)
Heterogeneity: Chi² = 4.51, df = 2 (P = 0.11); I² = 56% Test for overall effect: Z = 12.12 (P < 0.00001) Test for subgroup differences: Chi² = 4.51, df = 2 (P = 0.11), I² = 55.6% 
Mean
Total (95% CI)
Total events Heterogeneity: Tau² = 1.24; Chi² = 2.14, df = 1 (P = 0.14); I² = 53% Test for overall effect: Z = 2.27 (P = 0.02) 
Events
Total (95% CI)
Total events Heterogeneity: Chi² = 5.57, df = 2 (P = 0.06); I² = 64% Test for overall effect: Z = 6.14 (P < 0.00001) Test for subgroup differences: Chi² = 3.77, df = 2 (P = 0.15), I² = 46.9% Heterogeneity: Tau² = 6.11; Chi² = 2.41, df = 1 (P = 0.12); I² = 58% Test for overall effect: Z = 11.46 (P < 0.00001)
Gastric banding vs MT John 2008
Subtotal (95% CI) Heterogeneity: Not applicable Test for overall effect: Z = 9.09 (P < 0.00001)
Gastrectomy s MT Philip 2012
Subtotal (95% CI) Heterogeneity: Not applicable Test for overall effect: Z = 11.31 (P < 0.00001)
Biliopancreatic Diversion vs MT Geltrude 2012
Subtotal (95% CI) Heterogeneity: Not applicable Test for overall effect: Z = 10.48 (P < 0.00001)
Total (95% CI)
Heterogeneity: Tau² = 13.95; Chi² = 16.74, df = 4 (P = 0.002); I² = 76% Test for overall effect: Z = 12.40 (P < 0.00001) Test for subgroup differences: Chi² = 12.43, df = 3 (P = 0.006), I² = 75.9% 
Mean
Total (95% CI)
Heterogeneity: Chi² = 10.58, df = 4 (P = 0.03); I² = 62% Test for overall effect: Z = 8.05 (P < 0.00001) Test for subgroup differences: Chi² = 9.68, df = 3 (P = 0.02), I² = 69.0% 
Gastric banding vs MT John 2008
Subtotal (95% CI) Heterogeneity: Not applicable Test for overall effect: Z = 2.50 (P = 0.01)
Biliopancreatic Diversion vs MT Geltrude 2012
Subtotal (95% CI) Heterogeneity: Not applicable Test for overall effect: Z = 9.05 (P < 0.00001)
Total (95% CI)
Heterogeneity: Chi² = 12.93, df = 2 (P = 0.002); I² = 85% Test for overall effect: Z = 8.68 (P < 0.00001) Test for subgroup differences: Chi² = 12.93, df = 2 (P = 0.002), I² = 84.5% 
Mean
Total (95% CI)
Heterogeneity: Chi² = 36.80, df = 4 (P < 0.00001); I² = 89% Test for overall effect: Z = 0.19 (P = 0.85) Test for subgroup differences: Chi² = 35.63, df = 3 (P < 0.00001), I² = 91.6% 
Mean
